Quantcast
breaking news

Better for Breast Cancer?

By: Charlotte Ames
Updated: December 5, 2012
 A new study could change the current treatment for breast cancer.
 
It's recommended that breast cancer survivors take Tamoxifen for five years to keep the disease from recurring. But now researchers at Oxford University say patients need to take the drug for at least twice as long.

Every year about 230,000 women are diagnosed with  breast cancer.  Fifty-thousand are  young women who haven't gone through  menopause. Tamoxifen is the top drug treatment for that group since it blocks the hormone estrogen which can fuel tumors.

British researchers found  breast cancer patients who took the drug longer were less likely to die from the disease and less likely to have their cancer come back.

Dr. Judy Garber of the Dana Farber Cancer Institute says, "the benefits are particularly in the second ten years. That's very helpful I think for that group of women who have really been worrying until now."

Researchers say even women who completed Tamoxifen years ago  may consider going back on it.

Tamoxifen has side effects including increased risk for endometrial cancer, blood clots, hot flashes and nausea. But scientists say the risk of serious side effects is low.
 


 

Comments

Readers Feel...

hello
Related Content

All he wants is to be seizure-free....

Pertussis cases have been reported at two area schools....

Narcotics may cause erectile dysfunction....

Local woman in Russia for treatment....

State College vet. also does acupuncture....

Mouth device helps people hear....

Jolie has double mastectomy....

New technique better for ACL repair....

Combining formula and breastfeeding helps some newborns....

New program cuts down on C-sections....

 

 
 
 
 
©1998 - 2013 Wearecentralpa.com
Nexstar Broadcasting, Inc.
All Rights Reserved